181 related articles for article (PubMed ID: 31741619)
1. Flow Cytometric Evaluation of Traditional and Novel Surface Markers for the Diagnosis of Plasma Cell Dyscrasias.
Draxler DF; Wutzlhofer LM; Slavka G; Hübl W; Ludwig H; Schreder M; Reynolds J; Willheim M
Indian J Hematol Blood Transfus; 2019 Oct; 35(4):673-682. PubMed ID: 31741619
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic characterization of normal and abnormal plasma cells in bone marrow of newly diagnosed multiple myeloma patients.
Awasthi NP; Mishra S; Gupta G; Kumari S; Bajpayee A; Singh P; Husain N
Indian J Pathol Microbiol; 2023; 66(2):295-300. PubMed ID: 37077071
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic Characterization and Ploidy Analysis of Neoplastic Plasma Cells by Multiparametric Flow Cytometry.
Gupta R; Gupta P; Rahman K; Biswas S; Chandra D; Singh MK; Sarkar MK; Gupta A; Nityanand S
Indian J Hematol Blood Transfus; 2022 Jul; 38(3):473-480. PubMed ID: 35747566
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
Flores-Montero J; de Tute R; Paiva B; Perez JJ; Böttcher S; Wind H; Sanoja L; Puig N; Lecrevisse Q; Vidriales MB; van Dongen JJ; Orfao A
Cytometry B Clin Cytom; 2016 Jan; 90(1):61-72. PubMed ID: 26100534
[TBL] [Abstract][Full Text] [Related]
5. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.
Jeong TD; Park CJ; Shim H; Jang S; Chi HS; Yoon DH; Kim DY; Lee JH; Lee JH; Suh C; Lee KH
Korean J Hematol; 2012 Dec; 47(4):260-6. PubMed ID: 23320004
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of Bone Marrow Flow Cytometry Analysis in Patients With Plasma Cell Neoplasm in Thailand: A Single Institutional Study.
Limvorapitak W; Srisum-Ang T; Chimres C; Warnnissorn N; Kanitsap N
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e27-37. PubMed ID: 26796980
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric aberrancies in plasma cell myeloma and MGUS - correlation with laboratory parameters.
Gupta S; Karandikar NJ; Ginader T; Bellizzi AM; Holman CJ
Cytometry B Clin Cytom; 2018 May; 94(3):500-508. PubMed ID: 29316245
[TBL] [Abstract][Full Text] [Related]
8. [Utility of 8-colours multiparameter flow cytometry immunophenotyping of plasma cells for the management of monoclonal gammopathy].
Gressier M; Chaquin M; Lhermitte L; Asnafi V; Macintyre E; Brouzes C
Ann Biol Clin (Paris); 2013; 71(3):313-23. PubMed ID: 23747669
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotype of normal and myelomatous plasma-cell subsets.
Robillard N; Wuillème S; Moreau P; Béné MC
Front Immunol; 2014; 5():137. PubMed ID: 24744760
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic characterization and quantification of neoplastic bone marrow plasma cells by multiparametric flow cytometry and its clinical significance in Korean myeloma patients.
Cho YU; Park CJ; Park SJ; Chi HS; Jang S; Park SH; Seo EJ; Yoon DH; Lee JH; Suh C
J Korean Med Sci; 2013 Apr; 28(4):542-9. PubMed ID: 23580331
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma.
Lebel E; Nachmias B; Pick M; Gross Even-Zohar N; Gatt ME
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407416
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies.
Tembhare PR; Ghogale S; Tauro W; Badrinath Y; Deshpande N; Kedia S; Cherian K; Patkar NV; Chatterjee G; Gujral S; Subramanian PG
Cytometry B Clin Cytom; 2018 May; 94(3):509-519. PubMed ID: 29316178
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
Lin P; Owens R; Tricot G; Wilson CS
Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern-based recognition.
Das N; Dahiya M; Gupta R; Rai S; Singh S; Prajapati VK; Kumar L; Sharma A; Sahoo RK; Gogia A
Cytometry B Clin Cytom; 2022 Jul; 102(4):292-302. PubMed ID: 35212134
[TBL] [Abstract][Full Text] [Related]
15. The role of CD19 and CD27 in the diagnosis of multiple myeloma by flow cytometry: a new statistical model.
Cannizzo E; Carulli G; Del Vecchio L; Ottaviano V; Bellio E; Zenari E; Azzarà A; Petrini M; Preffer F
Am J Clin Pathol; 2012 Mar; 137(3):377-86. PubMed ID: 22338049
[TBL] [Abstract][Full Text] [Related]
16. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
van Velzen JF; van den Blink D; Bloem AC
Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
[TBL] [Abstract][Full Text] [Related]
17. Development of an unbiased, semi-automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates.
Post SR; Post GR; Nikolic D; Owens R; Insuasti-Beltran G
Cytometry B Clin Cytom; 2018 Sep; 94(5):602-610. PubMed ID: 29573142
[TBL] [Abstract][Full Text] [Related]
18. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.
Bezdekova R; Jelinek T; Kralova R; Stork M; Polackova P; Vsianska P; Brozova L; Jarkovsky J; Almasi M; Boichuk I; Knechtova Z; Penka M; Pour L; Sevcikova S; Hajek R; Rihova L
Br J Haematol; 2021 Oct; 195(1):95-107. PubMed ID: 34500493
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
20. [Comparison and analysis of minimal residual disease in multiple myeloma patients detected by 4-color and 8-color fluorescence antibody panels].
Wang YZ; Lu J; Hao L; Chang Y; He LL; Huang XJ; Liu YR
Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):272-278. PubMed ID: 28468086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
